Insights to help your lab survive and thrive in today’s pay-for-performance environment:

G2’s Lab Value Series!

G2 Intelligence provides timely, accurate and trusted analysis and advice that improves the business performance of diagnostic testing laboratories and related medical services providers.

Clients gain immediate benefit from exclusive insight on market trends, legal and regulatory developments, and innovations that directly affect their operations, financial performance, and competitive position.


Research Reports

Effective planning for your lab begins with G2’s actionable findings on diagnostic industry markets, business operations, and regulatory changes.

Diagnostics Market Analysis and Trends

LISO-cover_inside101613U.S. Clinical Laboratory and Pathology Testing 2013-2015: Market Analysis, Trends, and Forecasts
MISO-big-coverU.S. Molecular Diagnostic and Genomic Testing 2013-2015: Laboratory Industry Analysis, Trends, and Forecasts
lab-testing-geo-coverLab Testing in the Private Payer Market: Geographic, Segment and Trend Analyses

Strategy Operations and Management

aco-report_cover_insideLaboratory Services in Accountable Care Organizations
clinical-informatics_cover_insideClinical Informatics in the Laboratory: The New Value Generator
rapid-path_cover_insideImplementing Rapid Pathogen Testing for Cost Savings and Outcomes Improvement

Clinical Next-Gen Tumor Sequencing: Your Key to the Value-Driven Oncology Market

Advanced Blood Management: Generate Significant Savings While Improving Patient Outcomes

Reference Guides

Diagnostics Regulation, Compliance and Risk
G2-Compliance_cover_InsideLab Compliance Essentials: Navigating RAC Audits, False Claims Act, Stark and the Anti-Kickback Statute
medicares-molecular-tests_cover_insideMedicare’s New Payment System for Molecular Tests: Coding Methodology, Reimbursement Strategies, Rate Updates
CLIA_cover_insideCLIA Compliance: The Essential Reference for the Clinical Laboratory, 3rd Edition

Upcoming Events

Lab Revolution 2016
April 6-8, 2016
Sheraton Wild Horse Pass Resort & Spa

Lab Institute 2016
October 26-28, 2016
Hyatt Regency Washington on Capitol Hill
Washington, DC



Don’t Let Your Lab Become a “Take Down” Target for U.S. Law Enforcement Agencies!
Wednesday, December 9th
2:00-3:30 p.m. eastern time

Browse recordings of recent G2 webinars, including:

Lab and Pathology Coding and Billing Update for 2016 NEW

Lab Preparedness for Ebola: Lessons from the Field

Lessons for Laboratories: How Utilization Management Can Help Control Costs and Improve Outcomes

Next-Generation Sequencing: What Clinical Labs Need to Know

Proposed Policy and Payment Changes for 2015 and Beyond: What’s the Upshot for Labs and Pathologists?

Delivering Test Results to Patients: Practical Strategies for Labs

Making Sense of Hospital Outpatient Lab Test Packaging: What’s the Impact on Your Bottom Line?

Recent Labcasts include:

Tactics That Foster Accountability and Efficiency

Leverage Diagnostics to Extend Your Lab’s Value, Reduce Costs and Improve Outcomes

Creating 100% Accountability Within Your Lab

EMR Integration Got You Down? Learn One Lab’s Story of Success

3 Keys to Fueling Success Through Superior Service: How PGXL Labs Increased Client Retention While Optimizing Operations


Reduce your regulatory risk, and get an advanced view of industry changes that impact the value of your organization.

Laboratory Industry Report

Stay informed with accurate, practical updates on the critical events shaping the future of the diagnostic laboratory industry.

G2 Compliance Advisor

Reduce the regulatory risk and potential liabilities of your diagnostics practice. It’s a resource that no lab should be without.

National Intelligence Report

Governmental policy continually shapes the future for diagnostic testing services—does YOUR lab have the inside intelligence it needs to succeed?

Diagnostic Testing & Emerging Technologies

Innovation and rapid uptake are feeding the growth of diagnostic testing—what do these changes mean for you and your organization?

lab_and_pathology_insider_homeG2’s FREE, weekly email gives you access to G2 market analysis, regulatory changes, M&A activity, leadership moves and more on the diagnostics industry. Recent articles include:

FDA and CMS Address LDT Regulation Before Energy and Commerce Committee

USPSTF Recommendations Cut PSA Testing; More Personalized Screening Called For

Circulogene Releases Dipstick Test For Tumor Analysis

HCA Agrees to Pay $2 Million to Settle Claims of Unnecessary Lab Tests

First Name:
Last Name:
* Email Address: